Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Rebif hit again as competition bites

Merck Serono’s MS drug continues its struggle for sales in the US and Europe

- PMLiVE

Celltrion submits biosimilar Remicade for US approval

Drug is second to be assessed by FDA under biosimilars pathway

- PMLiVE

AZ takes asthma antibody into phase III

Tralokinumab tipped as potential blockbuster

- PMLiVE

FDA approves Merck’s insomnia drug

Belsomra is first orexin receptor antagonist available in US

- PMLiVE

Sanofi ships synthetic malaria jab

French manufacturer says Gates Foundation-funded venture could widen treatment

- PMLiVE

Amgen hit as Kyprolis fails myeloma study

Inability to improve overall survival could dent expanded use prospects

- PMLiVE

Pharma Perspectives with the HCC: Malik Akhtar on the pitching process

Bayer's category lead for agency services gives a pharma view

- PMLiVE

Pharma Perspectives with the HCC: Ben Davies on the pitching process

Havas Health's European CEO gives an agency view

- PMLiVE

Sanofi’s US pharma head joins Synta as CEO

Anne Whitaker also has experience at GSK

Arvato turns to Google for head of digital marketing

Jens Monsees was most recently at search engine giant

- PMLiVE

Huntsworth CEO to step down

Lord Chadlington to leave PR group

- PMLiVE

Phase III data back AZ’s gout drug

Lesinurad on course to be filed this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links